12:01⇢The iPS Cell Dawn and Iran's Martyrdom
⌨Japanese media editors are prioritizing two distinct developments: the world's first commercialization of iPS cell-derived regenerative medicine products, with multiple outlets reporting the conditional approval for Parkinson's disease and heart failure treatments (Asahi Shimbun, Kyodo News, TBS News, NHK News). Meanwhile, coverage continues on the escalating Iran crisis, including the death of Supreme Leader Khamenei as a martyr and the detention of two Japanese nationals (Mainichi Shimbun, NHK News, Nikkei Asia).